MedPath
HSA Product

NEODOL-50 TABLET 50 mg

Product approved by Health Sciences Authority (SG)

Basic Information

NEODOL-50 TABLET 50 mg

ENTERIC COATED TABLET

Regulatory Information

SIN09392P

June 19, 1997

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XM01AB05

Company Information

MICRO LABS LTD

NAINA MOHAMED & SONS PRIVATE LIMITED

NAINA MOHAMED & SONS PRIVATE LIMITED

Active Ingredients

DICLOFENAC SODIUM

Strength: 50 mg

Detailed Information

Contraindications

**CONTRAINDICATIONS:** Diclofenac is contraindicated in patients with history of Hypersensitivity, or active or suspected peptic ulcer or GI bleeding, and in those who are known to develop asthma, urticarial or other allergic reactions with aspirin or other NSAIDs. Acute porphyria is a contraindication for diclofenac. Hepatic and Renal insufficiency. Not recommended in pregnancy. The use of high dose diclofenac (150mg/day) for more than 4 weeks is contraindicated in patients with established cardiovascular disease (congestive heart failure, established ischemic heart disease, peripheral arterial disease) or uncontrolled hypertension.

Indication Information

**INDICATIONS AND USES:** Acute and chronic treatment of the signs and symptoms of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.

© Copyright 2025. All Rights Reserved by MedPath